- 現金殖利率: 1.99%、總殖利率: 1.99%、5年平均現金配發率: 50.03%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 (5) | 38.15 | 50.43 | 19.10 | 52.8 | 0.00 | 0 | 50.07 | 1.57 | 0.00 | 0 | 50.07 | 1.57 |
| 2024 (4) | 25.36 | 10.21 | 12.50 | 7.76 | 0.00 | 0 | 49.29 | -2.23 | 0.00 | 0 | 49.29 | -2.23 |
| 2023 (3) | 23.01 | -38.77 | 11.60 | -38.95 | 0.00 | 0 | 50.41 | -0.29 | 0.00 | 0 | 50.41 | -0.29 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 26Q1 (8) | 10.64 | 12.12 | 9.69 | 9.98 | 11.14 | 16.05 | 10.64 | -72.15 | 9.69 |
| 25Q4 (7) | 9.49 | 1.5 | 11.78 | 8.98 | 2.86 | 22.68 | 38.20 | 33.05 | 50.45 |
| 25Q3 (6) | 9.35 | -3.21 | 49.12 | 8.73 | -2.78 | 81.5 | 28.71 | 48.3 | 69.88 |
| 25Q2 (5) | 9.66 | -0.41 | 85.06 | 8.98 | 4.42 | 107.87 | 19.36 | 99.59 | 82.13 |
| 25Q1 (4) | 9.70 | 14.25 | 0.0 | 8.60 | 17.49 | 0.0 | 9.70 | -61.8 | 0.0 |
| 24Q4 (3) | 8.49 | 35.41 | 0.0 | 7.32 | 52.18 | 0.0 | 25.39 | 50.24 | 0.0 |
| 24Q3 (2) | 6.27 | 20.11 | 0.0 | 4.81 | 11.34 | 0.0 | 16.90 | 58.98 | 0.0 |
| 24Q2 (1) | 5.22 | 0.0 | 0.0 | 4.32 | 0.0 | 0.0 | 10.63 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/6 | 16.85 | 5.28 | 25.58 | 93.38 | 26.0 | 48.08 | N/A | - | ||
| 2026/5 | 16.0 | 5.11 | 20.86 | 76.53 | 26.1 | 46.29 | N/A | - | ||
| 2026/4 | 15.23 | 1.12 | 16.56 | 60.52 | 27.56 | 45.12 | N/A | - | ||
| 2026/3 | 15.06 | 1.43 | 25.64 | 45.3 | 31.74 | 45.3 | 1.95 | - | ||
| 2026/2 | 14.84 | -3.63 | 24.87 | 30.24 | 35.0 | 45.63 | 1.94 | - | ||
| 2026/1 | 15.4 | 0.1 | 46.45 | 15.4 | 46.45 | 45.59 | 1.94 | - | ||
| 2025/12 | 15.38 | 3.94 | 29.58 | 160.01 | 59.42 | 44.61 | 2.01 | 本期收入及合併子公司收入較去年同期增加,故本月收入較去年同期增加 | ||
| 2025/11 | 14.8 | 2.6 | 40.81 | 144.62 | 63.42 | 43.26 | 2.07 | 本期收入及合併子公司收入較去年同期增加,故本月收入較去年同期增加 | ||
| 2025/10 | 14.42 | 2.8 | 51.51 | 129.82 | 66.47 | 42.28 | 2.12 | 本期收入及合併子公司收入較去年同期增加,故本月收入較去年同期增加 | ||
| 2025/9 | 14.03 | 1.48 | 62.75 | 115.4 | 68.54 | 41.29 | 1.99 | 本期收入及合併子公司收入較去年同期增加,故本月收入較去年同期增加 | ||
| 2025/8 | 13.83 | 2.89 | 78.77 | 101.37 | 69.38 | 40.68 | 2.02 | 本期收入及合併子公司收入較去年同期增加,故本月收入較去年同期增加 | ||
| 2025/7 | 13.44 | 0.14 | 84.16 | 87.54 | 67.98 | 40.1 | 2.05 | 本期收入及合併子公司收入較去年同期增加,故本月收入較去年同期增加 | ||
| 2025/6 | 13.42 | 1.33 | 86.88 | 74.11 | 65.35 | 39.72 | 1.82 | 本期收入及合併子公司收入較去年同期增加,故本月收入較去年同期增加 | ||
| 2025/5 | 13.24 | 1.37 | 86.21 | 60.69 | 61.24 | 38.29 | 1.89 | 本期收入及合併子公司收入較去年同期增加,故本月收入較去年同期增加 | ||
| 2025/4 | 13.06 | 9.01 | 75.23 | 47.45 | 55.43 | 36.93 | 1.96 | 本期收入及合併子公司收入較去年同期增加,故本月收入較去年同期增加 | ||
| 2025/3 | 11.98 | 0.81 | 56.47 | 34.38 | 49.03 | 34.38 | 2.31 | 本期收入及合併子公司收入較去年同期增加,故本月收入較去年同期增加 | ||
| 2025/2 | 11.89 | 13.02 | 62.16 | 22.4 | 45.34 | 34.27 | 2.31 | 去年同期遇年假，工作日較少 | ||
| 2025/1 | 10.52 | -11.42 | 30.08 | 10.52 | 30.08 | 32.9 | 2.41 | - | ||
| 2024/12 | 11.87 | 12.95 | 38.68 | 100.37 | 0.05 | 31.9 | 2.35 | - | ||
| 2024/11 | 10.51 | 10.4 | 28.15 | 88.5 | -3.55 | 28.65 | 2.62 | - | ||
| 2024/10 | 9.52 | 10.42 | 17.48 | 77.99 | -6.66 | 25.87 | 2.9 | - | ||
| 2024/9 | 8.62 | 11.47 | 7.29 | 68.47 | -9.25 | 23.65 | 3.25 | - | ||
| 2024/8 | 7.73 | 5.99 | 3.06 | 59.85 | -11.23 | 22.21 | 3.46 | - | ||
| 2024/7 | 7.3 | 1.62 | 4.19 | 52.11 | -13.02 | 21.59 | 3.56 | - | ||
| 2024/6 | 7.18 | 0.96 | -4.56 | 44.82 | -15.29 | 21.75 | 3.36 | - | ||
| 2024/5 | 7.11 | -4.6 | -11.3 | 37.64 | -17.07 | 22.22 | 3.29 | - | ||
| 2024/4 | 7.45 | -2.66 | -8.68 | 30.52 | -18.31 | 22.44 | 3.26 | - | ||
| 2024/3 | 7.66 | 4.48 | -24.4 | 23.07 | -21.01 | 23.07 | N/A | - | ||
| 2024/2 | 7.33 | -9.33 | -28.33 | 15.41 | -19.2 | 23.97 | N/A | - | ||
| 2024/1 | 8.08 | -5.57 | -8.66 | 8.08 | -8.66 | 24.85 | N/A | - | ||
| 2023/12 | 8.56 | 4.37 | -20.3 | 100.32 | -33.35 | 24.86 | N/A | - | ||
| 2023/11 | 8.2 | 1.21 | -24.44 | 91.76 | -34.35 | 24.34 | N/A | - | ||
| 2023/10 | 8.1 | 0.84 | -36.07 | 83.55 | -35.19 | 23.64 | N/A | - | ||
| 2023/9 | 8.04 | 7.08 | -40.6 | 75.45 | -35.09 | 22.54 | N/A | - | ||
| 2023/8 | 7.5 | 7.15 | -44.05 | 67.42 | -34.37 | 22.03 | N/A | - | ||
| 2023/7 | 7.0 | -6.92 | -47.77 | 59.91 | -32.91 | 22.54 | N/A | - | ||
| 2023/6 | 7.52 | -6.16 | -43.78 | 52.91 | -30.29 | 23.7 | N/A | - | ||
| 2023/5 | 8.02 | -1.78 | -39.63 | 45.39 | -27.4 | 26.31 | N/A | - | ||
| 2023/4 | 8.16 | -19.42 | -38.08 | 37.37 | -24.1 | 28.52 | N/A | - | ||
| 2023/3 | 10.13 | -0.94 | -22.81 | 29.21 | -18.99 | 29.21 | N/A | - | ||
| 2023/2 | 10.23 | 15.55 | -14.86 | 19.08 | -16.79 | 29.82 | N/A | - | ||
| 2023/1 | 8.85 | -17.6 | -18.93 | 8.85 | -18.93 | 30.45 | N/A | - | ||
| 2022/12 | 10.74 | -1.04 | 0.38 | 150.52 | 30.24 | 34.27 | N/A | - | ||
| 2022/11 | 10.86 | -14.36 | 0.89 | 139.78 | 33.28 | 37.06 | N/A | - | ||
| 2022/10 | 12.68 | -6.29 | 19.33 | 128.93 | 36.99 | 39.61 | N/A | - | ||
| 2022/9 | 13.53 | 0.86 | 28.73 | 116.25 | 39.24 | 40.35 | N/A | - | ||
| 2022/8 | 13.41 | 0.02 | 41.66 | 102.72 | 40.75 | 40.2 | N/A | - | ||
| 2022/7 | 13.41 | 0.18 | 45.72 | 89.31 | 40.61 | 40.07 | N/A | - | ||
| 2022/6 | 13.38 | 0.76 | 48.55 | 75.9 | 39.75 | 39.85 | N/A | - | ||
| 2022/5 | 13.28 | 0.73 | 47.14 | 62.52 | 38.0 | 39.59 | N/A | - | ||
| 2022/4 | 13.18 | 0.45 | 40.52 | 49.24 | 35.72 | 38.32 | N/A | - | ||
| 2022/3 | 13.13 | 9.26 | 34.04 | 36.05 | 34.04 | 36.05 | N/A | - | ||
| 2022/2 | 12.01 | 10.03 | 23.13 | 22.93 | 34.05 | 33.63 | N/A | - | ||
| 2022/1 | 10.92 | 2.01 | 48.54 | 10.92 | 48.54 | 32.38 | N/A | - | ||
| 2021/12 | 10.7 | -0.53 | 130.82 | 115.57 | 83.25 | 32.08 | N/A | 去年累積同期受新冠肺炎影響 | ||
| 2021/11 | 10.76 | 1.28 | 39.17 | 104.87 | 79.48 | 31.89 | N/A | 去年累積同期受新冠肺炎影響 | ||
| 2021/10 | 10.62 | 1.09 | -5.57 | 94.11 | 85.62 | 30.6 | N/A | 去年累積同期受新冠肺炎影響 | ||
| 2021/9 | 10.51 | 10.99 | 6.33 | 83.49 | 111.63 | 29.18 | N/A | 去年累積同期受新冠肺炎影響 | ||
| 2021/8 | 9.47 | 2.88 | 77.88 | 72.98 | 146.82 | 0.0 | N/A | 去年同期受新冠肺炎影響 | ||
| 2021/7 | 9.2 | 2.13 | 134.42 | 63.51 | 161.95 | 0.0 | N/A | 去年同期受新冠肺炎影響 |